Nisa Investment Advisors LLC Trims Stock Position in Intuitive Surgical, Inc. $ISRG

Nisa Investment Advisors LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 111,592 shares of the medical equipment provider’s stock after selling 147 shares during the period. Nisa Investment Advisors LLC’s holdings in Intuitive Surgical were worth $60,640,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the stock. Chilton Capital Management LLC raised its holdings in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Elite Financial Inc. purchased a new stake in Intuitive Surgical during the 1st quarter worth about $26,000. LFA Lugano Financial Advisors SA acquired a new position in Intuitive Surgical in the 1st quarter valued at about $30,000. TD Capital Management LLC lifted its holdings in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares in the last quarter. Finally, 1248 Management LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth about $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.9%

Shares of ISRG opened at $546.51 on Friday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The firm has a market capitalization of $195.91 billion, a P/E ratio of 72.29, a price-to-earnings-growth ratio of 5.45 and a beta of 1.61. The stock’s fifty day simple moving average is $458.09 and its 200 day simple moving average is $497.29.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.84 earnings per share. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares in the company, valued at $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 40,724 shares of company stock valued at $19,500,332 in the last quarter. Company insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on ISRG. HSBC boosted their price objective on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research report on Thursday. Evercore ISI lowered their target price on shares of Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research note on Tuesday, October 7th. Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a research report on Tuesday. Finally, The Goldman Sachs Group dropped their target price on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research note on Wednesday, October 1st. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $602.32.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.